Collegium Pharmaceutical Inc
General ticker "COLL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $982.7M
Collegium Pharmaceutical Inc follows the US Stock Market performance with the rate: 4.8%.
Estimated limits based on current volatility of 2.1%: low 29.51$, high 30.78$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [22.93$, 35.75$]
- 2024-12-30 to 2025-12-30 estimated range: [22.52$, 35.96$]
Financial Metrics affecting the COLL estimates:
- Positive: Non-GAAP EPS, $ of 5.50 > 2.29
- Positive: Operating cash flow per share per price, % of 29.23 > 12.76
- Positive: Operating profit margin, % of 29.46 > 19.51
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Positive: -3.48 < Investing cash flow per share, $ of -2.10
Short-term COLL quotes
Long-term COLL plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $276.87MM | $463.93MM | $566.77MM |
| Operating Expenses | $259.24MM | $430.61MM | $399.81MM |
| Operating Income | $17.63MM | $33.32MM | $166.96MM |
| Non-Operating Income | $-21.00MM | $-62.17MM | $-91.23MM |
| Interest Expense | $21.01MM | $63.21MM | $83.34MM |
| R&D Expense | $9.45MM | $3.98MM | $0.00MM |
| Income(Loss) | $-3.37MM | $-28.85MM | $75.73MM |
| Taxes | $-74.89MM | $-3.85MM | $27.58MM |
| Profit(Loss) | $71.52MM | $-25.00MM | $48.16MM |
| Stockholders Equity | $202.93MM | $194.84MM | $195.43MM |
| Inventory | $17.39MM | $46.50MM | $32.33MM |
| Assets | $692.08MM | $1,174.13MM | $1,143.31MM |
| Operating Cash Flow | $103.56MM | $124.23MM | $274.75MM |
| Capital expenditure | $1.94MM | $1.62MM | $0.46MM |
| Investing Cash Flow | $-1.94MM | $-573.69MM | $-70.81MM |
| Financing Cash Flow | $-89.30MM | $436.72MM | $-140.18MM |
| Earnings Per Share* | $2.05 | $-0.74 | $1.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.